Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Bembridge

Dawn Bembridge, Cambridge GB

Patent application numberDescriptionPublished
20080213262Inhibition of Islet Amyloid Polypeptide (Iapp) Aggregation for the Treatment of Type 2 Diabetes - The present invention relates to the targeting and clearance of soluable unprocessed Islet Amyloid Polypeptide (hIAPP) in order to prevent the nucleation of hIAPP amyloidogenesis and to interfere with pancreatic cell death which is associated with the aggregation of hIAPP. Agents and methods for reducing hIAPP aggregation are provided herein and may be useful in the treatment of type 2 diabetes.09-04-2008

Dawn Ann Bembridge, Hertfordshire GB

Patent application numberDescriptionPublished
20090175923HUMANIZED ANTI-AMYLOID BETA ANTIBODIES - Humanized anti-Aβ antibodies derived from a murine antibody directed to a N-terminal epitope of Aβ are described. The humanized antibodies have reduced or no human T cell epitopes and bind Aβ with an affinity similar to that of the murine antibody.07-09-2009
20110177076HUMANIZED ANTI-AMYLOID BETA ANTIBODIES - Humanized anti-Aβ antibodies derived from a murine antibody directed to a N-terminal epitope of Aβ are described. The humanized antibodies have reduced or no human T cell epitopes and bind Aβ with an affinity similar to that of the murine antibody.07-21-2011

Gary Bembridge, Herts GB

Patent application numberDescriptionPublished
20100068226Polynucleotides and Uses Thereof - The present invention provides an isolated polynucleotide comprising or consisting of the nucleotide sequence encoding the G protein of human respiratory syncytial virus (RSV), wherein the nucleotide sequence is codon optimised for expression in mammalian cells and wherein the polynucleotide provides increased expression of the G protein in mammalian cells relative to expression of the wildtype RSV-G gene. Preferably, the polynucleotide comprises or consists of the nucleotide sequence of SEQ ID NO:2. Further aspects of the invention provide pharmaceutical compositions, in particular vaccines, for use in methods of immunising a subject against RSV infection.03-18-2010

Gary Peter Bembridge, Hertfordshire GB

Patent application numberDescriptionPublished
20110206686IL-23 ANTIBODIES - The present invention relates to antigen binding proteins to human IL-23, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as Rheumatoid Arthritis (RA).08-25-2011

Gary Peter Bembridge, Stevenage GB

Patent application numberDescriptionPublished
20090123479IMMUNOGLOBULINS - The present invention relates to antigen binding proteins to human IL-23, pharmaceutical formulations containing them and to the use of such antigen binding proteins in the treatment and/or prophylaxis of inflammatory diseases such as Rheumatoid Arthritis (RA).05-14-2009

Mathew L. Bembridge, Eindhoven NL

Patent application numberDescriptionPublished
20100133982LAMP, LAMP HOLDER, AND ASSEMBLY OF SUCH A LAMP AND SUCH A LAMP HOLDER - The invention relates to an assembly of a lamp and a lamp holder. The invention also relates' to a lamp' for use in an assembly of a lamp and a lamp holder. The invention further relates to a lamp holder for use in an assembly of a lamp and a lamp holder. Assembly of a lamp (06-03-2010

Mathew Lee Bembridge, Rotterdam NL

Patent application numberDescriptionPublished
20120091903LUMINAIRE COMBINING AMBIENT LIGHT AND TASK LIGHT - A luminaire is disclosed that allows a transfer from ambient light to task light through physical manipulation by the user. The luminaire comprises OLED light sources for generating an ambient light effect and LED light sources for generating a task light effect.04-19-2012

Mathew Lee Bembridge, Eindhoven NL

Patent application numberDescriptionPublished
20080316747Luminaire with Louver Members - The invention relates to a reflector for a luminaire. The reflector comprises a cavity (12-25-2008